The role of the insulin-like growth factor 1 receptor axis in multiple myelomaMENU, Eline; VAN VALCKENBORGH, Els; VAN CAMP, Ben et al.Archives of physiology and biochemistry. 2009, Vol 115, Num 2, pp 49-57, issn 1381-3455, 9 p.Conference Paper

Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneityASOSINGH, Kewal; DE RAEVE, Hendrik; MENU, Eline et al.Blood. 2004, Vol 103, Num 8, pp 3131-3137, issn 0006-4971, 7 p.Article

La biologie du myélome multiple élucidée sur des cellules souches cancéreuses, sur des altérations intracellulaires acquises et sur des interactions avec le micro-environnement = Unraveling the biology of multiple myeloma disease : cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environmentCAERS, Jo; VAN VALCKENBORGH, Els; MENU, Eline et al.Bulletin du cancer. 2008, Vol 95, Num 3, pp 301-313, issn 0007-4551, 13 p.Article

The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor PicropodophyllinLEMAIRE, Miguel; FRISTEDT, Charlotte; VAN CAMP, Ben et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2230-2239, issn 1078-0432, 10 p.Article

IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanismsDE BRUYNE, Elke; BOS, Tomas J; SCHUIT, Frans et al.Blood. 2010, Vol 115, Num 12, pp 2430-2440, issn 0006-4971, 11 p.Article

Inhibition of p38α mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myelomaVANDERKERKEN, Karin; MEDICHERLA, Satya; CROUCHER, Peter I et al.Cancer research (Baltimore). 2007, Vol 67, Num 10, pp 4572-4577, issn 0008-5472, 6 p.Article

The involvement of stromal derived factor 1α in homing and progression of multiple myeloma in the 5TMM modelMENU, Eline; ASOSINGH, Kewal; VANDERKERKEN, Karin et al.Haematologica (Roma). 2006, Vol 91, Num 5, pp 605-612, issn 0390-6078, 8 p.Article

Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma modelNUR, Haneen; RAO, Luigia; MENU, Eline et al.British journal of haematology. 2014, Vol 167, Num 5, pp 651-663, issn 0007-1048, 13 p.Article

Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myelomaCAERS, Jo; HOSE, Dirk; JANBOS, Tomas et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 163-167, issn 0390-6078, 5 p.Article

Bortezomib Alone or in Combination with the Histone Deacetylase Inhibitor JNJ-26481585: Effect on Myeloma Bone Disease in the 5T2MM Murine Model of MyelomaDELEU, Sarah; LEMAIRE, Miguel; VANDERKERKEN, Karin et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 13, pp 5307-5311, issn 0008-5472, 5 p.Article

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP : an in vitro and in vivo study in the 5T33MM mouse modelMENU, Eline; JERNBERG-WIKLUND, Helena; VANDERKERKEN, Kann et al.Blood. 2006, Vol 107, Num 2, pp 655-660, issn 0006-4971, 6 p.Article